T cells may be activated by the antigen-specific T cell receptor (TCR)-CD3 complex interacting either with foreign antigen in association with self-major histocompatibility complex (MHC) proteins or by foreign MHC proteins. T cells may also be activated by the cell surface receptor CD2 (T11, LFA-2, the T cell erythrocyte receptor), a molecule ofMr 50,000 expressed on all human thymocytes and T cells. Pairs of mAbs directed against different epitopes on CD2 will stimulate T cells (1) (2) (3) . While both the antigen-specific TCR and the CD2 pathways of T cell activation may be triggered independently, several lines of evidence suggest that they are functionally interrelated . Incubation of resting T cells with a nonstimulatory anti-CD3 mAb in the presence of an anti-CD2 mAb directed against a specific epitope (9-1 mAb) induces T cell stimulation (3) . Modulation of the TCRCD3 complex by incubation with an anti-CD3 mAb prevents subsequent activation by stimulatory pairs ofanti-CD2 mAb (1, 2, (4) (5) (6) . Whether CD3 expression is required for CD2-dependent activation or whether CD3 modulation induces a state of refractories to subsequent stimulation is not clear. Some (7) , but not all (6) , CD3-deficient mutant T cell lines may be stimulated by pairs of anti-CD2 mAb. On the other hand, while modulation of surface CD2 expression does not inhibit anti-CD3-induced calcium mobilization (5) , incubation of T cells with certain anti-CD2 mAb inhibits T cell stimulation through the TCRCD3 complex (8) (9) (10) (11) , suggesting that CD2 may regulate T cell responses.
A natural ligand for CD2 has been found to be lymphocyte function-associated antigen 3 (LFA-3),' a widely distributed cell surface glycoprotein of Mr 55,000-70,000 . CD2 on the T cell participates in antigen-independent adhesion or conjugate formation by binding to LFA-3 on the stimulator or target cell (12) (13) (14) (15) . In addition to T cell adhesion, the CD2/LFA-3 interaction plays a role in T cell activation (16) (17) (18) . Incubation of resting T cells with sheep erythrocytes, which bear an LFA-3 homologue, in the presence of one anti-CD2 mAb induces human T cell proliferation (16) . Murine L cells transfected with and expressing human LFA-3 together with an anti-CD3 mAb or with suboptimal concentrations of phytohemagglutinin stimulate proliferation of human peripheral blood T cells (17) .
To investigate the interaction of the CD2 activation pathway with the antigenspecific TCR pathway, we have expressed a cDNA encoding the human CD2 molecule in a murine T cell hybridoma that responds to HLA-DR antigens . We have previously shown that this hybridoma produces IL-2 upon stimulation with pairs of anti-CD2 mAb, such as 9.6 and 9-1 mAb, or with 9-1 mAb in the presence of murine L cells expressing human LFA-3 (18) , demonstrating that the CD2 pathway of activation is functional . CD2 expression markedly enhances IL-2 production in response to LFA-3+ antigen-bearing stimulator cells, and this stimulation is inhibited by anti-CD2 and anti-LFA-3 mAb.
To further define the role of LFA-3 in antigen-dependent T cell activation, we have studied the ability of the purified ligands of CD2 and the TCR to stimulate the hybridoma. The HLA-DR-specific murine T cell hybridoma expressing CD2 produced IL-2 after stimulation with liposomes containing purified LFA-3 and HLA-DR, the physiological ligands for CD2 and the TCR, respectively, suggesting that complementary interactions between the TCRCD3 complex and the CD2 pathway may regulate lymphocyte activation . We have also constructed a cytoplasmic deletion mutant of CD2, CD2AB, to examine the role of the CD2/LFA-3 interaction . The behavior of hybridomas expressing CD2AB allow a clear distinction to be made between the roles of adhesion and that of activation for the CD2/LFA-3 interaction . Deletion of the cytoplasmic domain of CD2 did not alter binding of LFA-3 but eliminated the ability of CD2 to increase the response of the hybridoma to liposomes containing both HLA-DR and LFA-3. These results suggest that the CD2/LFA-3 interaction not only plays a role in cell-cell adhesion but provides a stimulatory signal for T cell activation .
Materials and Methods
Cell Culture. Cell lines were grown in DMEM (M . A. Bioproducts, Bethesda, MD) supplemented with 10% heat-inactivated FCS (Hazelton Research Products, Denver, PA), penicillin 100 U/ml (Gibco Laboratories, Grand Island, New York), streptomycin 100 ug/ml (Gibco Laboratories), 10 mM Hepes (M . A . Bioproducts), and 2 mM glutamine (Gibco Laboratories). All assays for IL-2 were performed in RPMI-1640 (M . A. Bioproducts) supplemented as above and including 50 pM 2-ME (Eastman Organic Chemicals, Rochester, NY) .
Monoclonal Antibodies . Antibodies against LFA-3 (TS2/9) and CD2 (TS2/18) have been previously described (19) , and were used as ascites fluid or purified antibody. Additional anti-CD2 mAb were obtained through the Third International Workshop on Leukocyte Typing (20) . F23 .1, murine IgG, specific for V08 variable region of the murine TCR (21) ; 100 .30 .3 rat IgG26, specific for murine H-2k' (22) ; and LB3 .1, murine IgG1, specific for monomorphic determinants of HLA-DR (23), were also used .
Production of CD2-and CD2AB-expressing Cell Lines. The CD2-expressing T cell hybridomas were constructed as previously described (18) . CD2AB was constructed by cleavage of a CD2 cDNA with Ban II, treatment of the end with T4 DNA polymerase followed by liga-tion to 12-mer Nhe I linkers (stop codon linkers ; New England Biolabs, Beverly, MA) . Digestion of the resulting plasmid with Hind III and Bam HI released an 800-bp fragment ; this was then introduced into the retroviral vector MNCstuffer (A. Peterson, unpublished) . This deletion removes the COOH-terminal 100 amino acids of CD2 and replaces them with a serine.
CD2 and CD20B producer lines were constructed, and infections were done as described (24) . Briefly, the murine T cell hybridoma 155.16, produced by the fusion of the HATsensitive thymoma BW5147 with spleen cells from C57BL/6 mice primed with the human EBV transformed cell line JY (24) , was infected with defective retroviruses that impart resistance to G418 and either CD2 or CD2AB expression to the host cell . Neomycin-resistant cell lines were screened for wild-type or mutant CD2 expression by indirect immunofluorescence.
Immunofluorescent Flow Cytometry. 5 x 105 hybridoma cells were washed twice with PBS containing 2% FCS and 0.02% sodium azide, and then incubated at 4°C in the dark for 30 min with saturating concentrations of mAb. Cells were washed as above and incubated with 5 pl FITC-conjugated goat F(ab')2 anti-mouse IgG antibody (FITC-GAM) (Tago Inc., Burlingame, CA) at 4°C for 30 min. Cells were washed twice and incubated with 10 nM propidium iodide (Sigma Chemical Co., St. Louis, MO) in PBS. 5-10 x 103 cells were analyzed on an Epic V (Coulter Electronics, Hialeah, FL) fluorescence-activated cell sorter, during which dead cells were excluded by propidium iodide fluorescence.
Purification of LFA-3. The purification of LFA-3 by affinity chromatography has been described (16) . In brief, purified anti-LFA-3 mAb TS 2/9 was coupled to cyanogen biomide-activated Sepharose CL-4B (Pharmacia Fine Chemicals, Piscataway, NJ) as described (16) to prepare the anti-LEA-3 affinity columns . JY cells were solubilized with 2% Triton X-100 in PBS and were filtered. LFA-3 was purified from the lysate using an anti-LFA-3 column, washed with 0.5°Jo Triton X-100 in PBS, and eluted as described (16) . The eluted protein was homogeneous as shown by SDS-PAGE and retained serological activity as demonstrated by dot blot analysis.
Preparation ofHLA-DR and LFA-3 Liposomes. For preparation of HLA-DR, JY membranes were solubilized with 4% Nonidet P-40 as described (26) . The HLA-DR antigen was immunoaf$nity purified by passage of solubilized membranes through preclearing columns of Sepharose CL-4B, normal rabbit serum coupled to Sepharose CL-4B, and protein A-Sepharose, followed by an anti-HLA-DR column made by coupling the mAb LB3 .1 (23) to protein A-Sepharose . The column was eluted with 50 mM glycine/0 .1% sodium deoxycholate, pH 11 .5. The fractions were neutralized with 2 M glycine, pH 2, dialyzed and concentrated by ultrafiltration . The purified, detergent-solubilized HLA-DR (40 pg), purified LEA-3 (20 Vg), and purified HLA-DR (40 pg) with LFA-3 (20 pg) (DR + LFA-3) were each combined with detergent-solubilized JY membrane lipids (800 pg) from a chloroform/methanol extraction . Liposomes were formed by removal of the detergent by dialysis, as described previously (23) . The resulting liposomes were pelleted by centrifugation at 175,000 g for 1 h and resuspended in Tris-buffered saline .
Stimulation of IL-2 Production by T Cell Hybridomas. 5 x 104 T cell hybridomas were incubated with irradiated (100 cGy from a cesium source) JY stimulator cells or liposomes as indicated, with or without mAb, in 0.6 ml RPMI-1640 complete media in 48-well flat-bottom plates (Costar, Cambridge, MA). Cells were incubated for 24 h at 37°C in 5% C02 in air. Culture supernatants were harvested, frozen, thawed, titrated by serial twofold dilutions, and assayed for the presence of IL-2 by their ability to support the proliferation of an IL-2 dependent murine T cell line, CTLL-20 (27) . Proliferation was assessed by the incorporation of [3H]thymidine in a 4-h pulse after a 20-h incubation . Results are expressed relative to the [3H]thymidine incorporation of CTLL-20 cultured with a standard rat Con A supernatant, in which half-maximal incorporation is defined as 100 U IL-2/ml .
Results
T Cell Hybridomas Expressing CD2 Respond to Antigen Stimulation and to Liposomes Containing HLA-DR and LFA-3. A murine T cell hybridoma, 155 .16, was produced by the fusion of the murine AKR thymoma BW5147 with C57BL/6 spleen cells stimulated with the human EBVtransformed jY cell line and screened for antigen-specific IL-2 production . The parent cell line 155 .16, which produced IL-2 in response to stimulation with HLA-DR antigens (24) , was infected with a defective retrovirus that imparts resistance to G418 and surface expression of the human CD2 molecule as described (18) . We have previously demonstrated that murine T cell hybridomas expressing CD2 responded to pairs of anti-CD2 mAb such as 9.6 plus 9-1 mAb, or to the combination of 9-1 mAb and either sheep erythrocytes or murine L cells expressing human LFA-3 (18) . This suggests that CD2 expressed by the murine hybridoma was functional and that LFA-3 may replace the signal provided by 9.6 mAb binding.
Expression of the CD2 molecule in the murine hybridoma 155.16 markedly enhanced IL-2 production in comparison to the parent hybridoma in response to antigenspecific stimulation with the HLA-DR' JY cell line (Fig. 1) . While there was clonal variability in responsiveness, the CD2' hybridomas produced an average of 10-fold (range 3-30-fold) more IL-2 than the parent cell line to the same number of JY stimulator cells (data not shown) . CD2' hybridomas that express equivalent levels of CD2 and the TCR, as assessed by indirect immunoflourescence, were compared (data not shown) . In response toJY cell stimulation, 16.CD2-15 produced approximately 10-20-fold more IL-2, and 16.CD2-43 produced three-to sixfold more IL-2, compared with the parent line. Stimulation of the CD2' hybridomas, but not the parent, was inhibited by mAb directed against either CD2, expressed on the hybridoma, or LFA-3, expressed on theJY stimulator cells, suggesting that the CD2/LFA-3 interaction augmented the antigen-dependent response (Fig . 1) .
To define the role of LFA-3 in antigen-dependent T cell stimulation, we investigated whether purified LFA-3 and HLA-DR proteins incorporated into liposomes would stimulate the CD2' murine T cell hybridomas. LFA-3 and HLA-DR antigens were immunoaffinity purified from JY cells and the purified proteins were incorporated into liposomes. Neither the parent nor the CD2' hybridomas produced IL-2 when liposomes containing only purified HLA-DR antigens were added (Table I) . However, the CD2' hybridomas, 16.CD2-15 and 16.CD2-18, but not the parent hybridoma, produced IL-2 in response to incubation with liposomes containing both LFA-3 and HLA-DR antigens incorporated into the same liposome (DR + LEA-3-liposomes) (Table I) . LFA-3 liposomes alone did not stimulate IL-2 production . Purified HLA-A2 incorporated into liposomes with HLA-DR antigens did not stimulate IL-2 production (data not shown) . Thus, stimulation appeared to require the presence of both HLA-DR, the ligand for the TCR, and LFA-3.
Monoclonal antibody inhibition of the response of 16.CD2-15 to [DR + LFA-3]-liposome stimulation was compared with that ofjY cell stimulation (Fig . 2) . Both anti-CD2 (TS2/18) and anti-LFA-3 (TS2/9) mAb substantially inhibited IL-2 production in response to both stimuli. Similarly, mAb directed against monomorphic determinants of HLA-DR (LB3 .1) inhibited both stimulations . However, mAb directed against murine MHC class I antigen H-2kk (100.30.3) did not inhibit IL-2 production. These data demonstrated that stimulation of IL-2 production was dependent upon expression of CD2 on -the T cell, and upon the LFA-3 and HLA-DR antigens expressed on the stimulator cell or in liposomes. Expression and Function of CD2AB Molecules in the Murine T Cell Hybridoma. The CD2/LFA-3 interaction may participate in antigen-dependent T cell stimulation by increasing adhesion of the stimulator cell to the T cell and/or by providing a signal required for T cell activation . LFA-3 incorporated into [DR + LFA-3]-liposomes may allow adhesion to CD2 on the T cell, promoting the interaction of the TCR with HLA-DR antigens . To determine whether the CD2/LFA-3 interaction participates in cell-cell adhesion and provides an activation signal, we have constructed a cytoplasmic deletion cDNA mutant of CD2, CD2AB, in which the COON-terminal 100 amino acids of CD2 have been replaced with a serine (Fig . 3) . 155.16 was infected with a defective retrovirus that imparts resistance to G418 and surface expression of CD2AB. G418-resistant cell lines were analyzed by indirect immunofluorescence for CD2AB expression . Eight cell lines that expressed the murine TCR and mutant CD2AB molecules at levels equivalent to the wild-type CD2+ hybridomas were chosen for further study, an example of which is shown in Fig. 4 . The expression of the murine TCR, assessed by indirect immunofluorescence using F23.1, an mAb specific for the V08 region of the TCR, was equivalent on the parent hybridoma, the CD2+ hybridoma 16.CD2-15, and the hybridoma expressing the deletion mutant 16 .CD2AB-7 (Fig . 4) . Indirect immunofluorescence of the CD2+ and CD2AB' hybridomas using a panel of anti-CD2 mAb was equivalent (Fig . 4 and data not shown) . The expression of the LFA-1 molecule was equivalent on all cell lines (data not shown) . Eight hybridomas expressing the CD2AB molecule were analyzed . All eight CD2AB' cell lines were able to produce equivalent amounts of IL-2 as the wild type CD2' hybridomas upon stimulation with phorbol-12-myristate-13-acetate and the calcium ionophore ionomycin (data not shown) . No CD2AB' hybridoma responded to combinations of stimulatory pairs of anti-CD2 mAb, such as 9 .6 or 9-1 (Table  II and data not shown) . Four CD2AB' T cell hybridomas showed no enhanced responsiveness to JY stimulation, and four deletion mutants showed a slight enhancement of IL-2 production (1 .5-2-fold) in comparison to the parent 155 .16 (Table II and data not shown) . Of the eight CD2AB' hybridomas, the most responsive cell line, 16 .CD2AB-7, was analyzed for LFA-3 adhesion . 16 .CD2AB-7 retains the ability to bind purified LFA-3 comparably to the wild type CD2' hybridoma. Scatchard analysis of the binding of a soluble form of LFA-3 to the hybridomas expressing CD2 and the CD2AB mutants showed that both had a Kd of 30 nM (A . Peterson, manuscript in preparation) . Expression of the murine TCR and human CD2 molecules by the murine T cell hybridomas . Representative flow cytometric histograms are shown for the parent hybridoma 155.16, the CD2' hybridoma 16 .CD2-15, and the CD2AB' hybridoma 16 .CD2AB-7 . Hybridomas were stained with saturating concentrations of mAb directed against the TCR (F23 .1) and CD2 (9.6, 9.1) molecules, followed by incubation with FITC-GAM as described in Materials and Methods. The negative controls were cells stained with FITC-GAM alone.
Since the hybridoma 16.CD2AB-7 was able to bind LFA-3 but unable to be stimulated by pairs of anti-CD2 mAb, stimulation with [DR + LFA-3]-liposomes was then assessed . Unlike the hybridomas expressing the wild type CD2 protein, the CD2AB' did not respond to [DR + LFA-3]-liposomes (Table III) , demonstrating 5 x 104 hybridoma cells were cultured for 24 h with irradiated JY cells (104 cells/well), or with mAb as indicated . 9.6, MTI10, MT910, and 9-1 mAb were used at a final concentration of 1 ug/ml. Incubation of the hydridomas with each anti-CD2 mAb alone did not stimulate IL-2 production (data not shown) . Culture supernatants were assayed for the presence of IL-2 as described in Materials and Methods.
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Discussion
In this report, we have demonstrated that murine T cell hybridomas expressing the human CD2 molecule produce IL-2 in response to stimulation with purified LFA-3 and HLA-DR incorporated into liposomes. LFA-3 may participate in antigendependent T cell stimulation via CD2 by promoting adhesion of the target or stimulator cell to the T cell and/or by providing an activating signal to the T cell . In immune interactions, adhesion preceeds antigen recognition and T cell activation, and these functions are therefore complementary. Stimulation of CD2+ hybridomas by liposomes containing both LFA-3 and HLA-DR proteins would be consistent with either role, since LFA-3 adheres to CD2 on the T cell and may allow the TCR to interact with HLA-DR antigens more efficiently. Like antigen stimulation, the [DR + LFA-3]-liposome stimulation of the CD2+ hybridomas may be inhibited by mAb directed against CD2, LFA-3, or HLA-DR .
The CD2AB+ hybridomas expressing a cytoplasmic deletion mutant of CD2 bind LFA-3 comparably to wild-type CD2, but are ineffective in allowing stimulation with [DR + LFA-3]-liposomes . The Kd of CD2AB expressed in the hybridoma for LFA-3 is the same as that of wild-type CD2. Furthermore, the CD2AB and wild-type CD2 molecules transfected into COS cells both promote adhesion to sheep erythrocytes, which express the sheep homologue of LFA-3 (A . Peterson, unpublished) . If adhesion alone were responsible for CD2-mediated stimulation of the hybridomas response to antigen, then this mutant should be as effective as wild-type CD2. However, no response is elicited by [DR + LFA-3]-liposomes . Thus, in this system, it appears that a predominant effect of the CD2/LFA-3 interaction is to provide an intracellular signal that synergizes with the signal provided by stimulation of the TCRCD3 complex. This conclusion is supported by the response of the CD2AB+ hybridomas to incubation with intact JY cells, in which there was, at most, a slight enhancement of IL-2 production compared to the parent hybridoma. This enhancement could be attributed to the more limited role of adhesion . We have previously shown that a hybridoma expressing a point mutant of CD2, Q51L CD2, with a single amino acid substitution at position 51 of glutamine for leucine, did not react with the 9.6 mAb, but had retained binding to and could be stimulated to produce IL-2 to other anti-CD2 mAb with 9-1 mAb (18) . The Q51L CD2+ hybridomas did not respond to sheep erythrocytes nor murine L cells transfected with and expressing human LFA-3 plus 9-1 mAb (18), demonstrating that the Q51L CD2 molecule is unable to use LFA-3 for activation . Unlike the hybridomas expressing the wild type CD2 molecule, the Q51L CD2 + hybridomas did not exhibit enhanced IL-2 production in response to antigen-specific JY stimulation (18) . These findings support the conclusion that the inability of Q51L CD2+ hybridomas to demonstrate an enhanced response to JY cell stimulation is due to the inability to bind LFA-3 expressed on the stimulator cell . The Q51L CD2+ hybridoma did not respond to stimulation with [DR + LFA-3]-liposomes (data not shown) . These data provide further evidence that the enhanced response observed with the wild type CD2+ hybridoma is specific and depends upon the ability of LFA-3 to bind to CD2 .
We (18) and others (16) have shown that LFA-3 binding to CD2, in the presence of one anti-CD2 mAb, induces antigen-independent T cell activation . Furthermore, the CD2/LFA-3 interaction may affect T cell stimulation via the TCRCD3 pathway. Resting human T cells may be stimulated to proliferate by one anti-CD3 mAb in the presence of murine L cells expressing human LFA-3 (17) or by an anti-CD2 mAb (9-1) (3). Two signals are necessary to stimulate T cells by the CD2 pathway. T cell function may be triggered by pairs of anti-CD2 mAb (1-3), or by one anti-CD2 mAb in the presence of either an anti-CD3 mAb (3) or LFA-3 (16, 18) . LEA-3 is widely expressed on nucleated cells (9) ; however, the interaction of CD2 with LFA-3 alone is insufficient for stimulation. Given the necessity for antigen to regulate the T cell immune response in the periphery, the second signal for T cell stimulation may be provided not through CD2, but through the TCR interacting with specific antigen. The CD2/LFA-3 interaction may provide an accessory function to augment a weak antigen-driven response. In this report, we have shown that T cells may be activated by purified LFA-3 binding to CD2 and the TCR interacting with its ligand, and that these signals are synergistic for the T cell . These findings extend previous data on the biological role of the interaction of LEA-3 with CD2, -and of the interrelationship of CD2 and the TCR. The signal provided by binding LFA-3 to CD2 alone is insufficient for activation but may contribute to antigen-dependent T cell activation . A second signal, here provided by the TCR interacting with its ligand, is required for T cell activation. Whether a quaternary complex formed among CD2 and the TCRCD3 complex on the T cell, and LFA-3 and antigen/MHC on the stimulator cell, allows for potentiation of these signals remains to be determined . Summary T cells may be activated either by the antigen-specific T cell receptor (TCR)-CD3 complex or the cell surface receptor CD2 . A natural ligand for CD2 has been found to be lymphocyte function-associated antigen 3 (LEA-3), a widely distributed cell surface glycoprotein . To investigate the interaction of these two pathways, we have expressed the cDNA encoding the human CD2 molecule in a murine T cell hybridoma that produces IL-2 in response to HLA-DR antigens . Expression of the CD2 mole-cule markedly enhances IL-2 production in response to LFA-3 + antigen-bearing stimulator cells, and this stimulation is inhibited by anti-CD2 and anti-LFA-3 mAb. To further define the role of LFA-3 in antigen-dependent T cell activation, we have studied the ability of the purified ligands of CD2 and the TCR to stimulate the hybridoma. Neither liposomes containing purified HLA-DR antigens nor liposomes containing purified LFA-3 were able to stimulate the parent or the CD2+ hybridoma. However, liposomes containing both purified LFA-3 and HLA-DR, the physiological ligands for CD2 and the TCR, respectively, stimulate IL-2 production by the CD2+ but not the parent hybridoma, suggesting that complementary interactions between the TCRCD3 complex and the CD2 pathway may regulate lymphocyte activation .
To determine whether the CD2/LFA-3 interaction participates in cell-cell adhesion and provides an activation signal, we have constructed a cytoplasmic deletion mutant of CD2, CD2AB, in which the COOH-terminal 100 amino acids of CD2 have been replaced with a serine . Hybridomas expressing the CD2AB molecule were examined . Deletion of the cytoplasmic domain of CD2 did not alter binding of LFA-3 but eliminated the ability of CD2 to increase the response of the hybridoma to liposomes containing both HLA-DR and LFA-3, demonstrating that adhesion of LFA-3 to CD2 alone was insufficient for activation, and that the cytoplasmic domain was required for LFA-3 stimulation through the CD2 molecule . T cells may be activated by purified LFA-3 binding to CD2 and the TCR interacting with its ligand, and these signals appear to be synergistic for the T cell. These results suggest that the CD2/LFA-3 interaction not only plays a role in cell-cell adhesion but provides a stimulatory signal for T cell activation .
